Towa International is the international company of Towa Pharmaceutical. We work to research, develop, manufacture and market generic and value-added medicines (VAM) that contribute to improving people’s health. At Towa, innovation is patient-centric. For this, our aim is to offer Towa’s value-added products in Europe and the US where we market directly and we distribute to more than 60 countries through strategic alliances to reach the largest number of patients in the world. We have three business units that complement each other while operating independently. They respond to different and specific business and regulatory needs: ◆ Breckenridge Pharmaceutical (Towa U.S.) ◆ Towa Europe (Towa Pharmaceutical Italy, Spain and Portugal) ◆ Towa 2B (Worldwide)